Bortezomib/bendamustine/dexamethasone induced good PR in refractory relapse post auto-SCT with constitutive RAS activation due to V600E BRAF mutation
Crossref DOI link: https://doi.org/10.1038/bmt.2014.192
Published Online: 2014-08-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chim, C S
Wong, K Y
Text and Data Mining valid from 2014-08-18
Version of Record valid from 2014-08-18
Article History
First Online: 18 August 2014
Competing interests
: The authors declare no conflict of interests.